LSD Therapy for Alcoholism
Project CBD
AUGUST 4, 2021
During the 1950s, LSD therapy showed great promise of treating the “spiritual disease” of alcoholism.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Project CBD
AUGUST 4, 2021
During the 1950s, LSD therapy showed great promise of treating the “spiritual disease” of alcoholism.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Project CBD
OCTOBER 31, 2019
The use of cannabis as medicine for animals has been getting a lot attention in the medical, scientific, and pet owning communities. One of the potential uses showing the most promise is in the treatment of seizures. Does it work as well for pets as it does for people?
Leafly
NOVEMBER 2, 2021
The post Would psychedelic therapy work without tripping? When psychedelic medicine is effective, is it pure chemistry—or is the experience of the trip essential? appeared first on Leafly.
Leafly
DECEMBER 19, 2022
Quebec became the first place to cover psilocybin-assisted therapy under medical insurance last week, another push to legalize psilocybin and other psychedelics for medical benefits. The post Quebec covers psilocybin therapy under medical insurance in historic first appeared first on Leafly.
The Fresh Toast
JANUARY 19, 2021
OCD And Cannabis Therapy: Recent Studies Show Progress. About one-third of people with OCD don't experience benefits from traditional therapy or medicines according to a 2020 study. The post OCD And Cannabis Therapy: Recent Studies Show Progress appeared first on The Fresh Toast.
Project CBD
AUGUST 3, 2020
An oncologist and an osteopath discuss cannabis therapy for cancer patients.
Project CBD
APRIL 7, 2020
Could cannabidiol be a breakthrough therapy to replace or lessen the use of steroids?
NORML
JUNE 19, 2020
“Taken together, the results of this study add to the cumulative evidence in support of plant-based MC (medical cannabis) as a safe and effective treatment option and potential opioid substitute or augmentation therapy for the management of chronic pain symptomatology and quality of life.”.
Project CBD
SEPTEMBER 8, 2021
Cannabis therapies have produced positive results for a wide range of mental health conditions, including stuttering, dementia, and social isolation.
Veriheal
DECEMBER 15, 2023
MAPS Public Benefit Corporation (PBC), an arm of the Multidisciplinary Association for Psychedelic Studies , has made big strides recently encouraging the Food and Drug Administration (FDA) to consider approving MDMA, also known as molly or ecstasy, for MDMA-assisted therapy.
Cannabis Life Network
OCTOBER 14, 2021
The post CBG is safe, gets green light for clinical trials and therapy appeared first on Latest Cannabis News Today - Headlines, Videos & Stocks. Even as a common name, CBG had yet to undergo the same tests and clinical trials as CBD to ensure high doses are safe. That has since begun to change, especially with a […].
NORML
JUNE 18, 2019
” Patients were most likely to report overall reductions in pain and overall improvements in their quality of life following cannabis therapy. … Future studies should aim to compare medical cannabis to the standard therapy of fibromyalgia, to establish the proper place of cannabis in fibromyalgia therapeutic arsenal.”
Project CBD
SEPTEMBER 28, 2020
A doctor’s account of a young man with Crohn’s disease who benefited greatly from cannabis therapy.
Veriheal
MARCH 23, 2022
Bronner’s expressed gratitude and excitement for its new partnership with healthcare organization Enthea to expand its employee medical benefits to include psychedelic therapies. Why Psychedelic Therapies? Enthea reports many astounding statistics surrounding psychedelic-assisted therapy studies.
Leafly
FEBRUARY 7, 2023
The post Tripping with your significant other: Healing with psychedelic couples therapy appeared first on Leafly. A single psychedelic session can transform one’s perspective, and help couples work through relationship issues.
Project CBD
OCTOBER 17, 2019
How close are we to an approved cannabis therapy for cancer? Medical cannabis science pioneer Dr. Manuel Guzman discusses the successes and challenges towards acceptance in the medical community.
NORML
MAY 13, 2024
That is why, some 50 years after NORML first began this fight, I am pleased to see the federal government finally acknowledge what we – and millions of Americans – have known all along: That marijuana is a legitimate therapy for many Americans and that it doesn’t belong in Schedule I.
Veriheal
MARCH 1, 2022
The first legal psilocybin therapy program to take shape in America is slowly progressing in Oregon. Kate Brown conducts regularly scheduled monthly meetings with a goal of shaping the nation’s first Psilocybin therapy program. Oregon’s Psilocybin Therapy Program: Advisory Board Hard at Work. ” . .”
Project CBD
AUGUST 3, 2020
An oncologist and an osteopath discuss cannabis therapy for cancer patients.
Project CBD
MARCH 2, 2020
Recently NIDA supported a clinical trial which used nicotine as a therapy for relatively mild cannabis withdrawal symptoms.
Veriheal
AUGUST 4, 2023
What DMT can teach us about dying, ketamine infusion therapy provides hope for fibromyalgia patients, and “Cocaine Shark” steals headlines. Patients considering this cutting-edge therapy will first need to undergo a clinical assessment. Let’s dive into this week’s canna-news.
NORML
OCTOBER 30, 2020
"We conclude that phytocannabinoids can be a low-cost and well-tolerated therapy for symptom relief and quality of life improvement in these patients.". The post Clinical Trial: Plant-Derived Cannabis Oil Effective for Patients with Fibromyalgia appeared first on NORML.
NORML
MAY 14, 2021
"The most vulnerable Mississippians will continue to be denied safe access to a therapy that could offer them significant relief from severely debilitating conditions.”. The post Mississippi: Supreme Court Nullifies Voter-Approved Medical Cannabis Initiative appeared first on NORML.
NORML
AUGUST 4, 2020
Some opponents of marijuana policy reform have manipulated the Speaker’s comments to imply that she was opining that cannabis therapy has been proven specifically to be successful for the treatment of COVID-19. The post McConnell Misleads on Marijuana appeared first on NORML.
NORML
JULY 30, 2020
The most significant new measure, House Bill 819, expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that they consider “debilitating to an individual patient.”. The post Louisiana: Medical Cannabis Expansion Laws Take Effect appeared first on NORML.
NORML
FEBRUARY 19, 2021
“The current study revealed the positive effects of MC [medical cannabis] therapy in some patients with FMS [ fibromyalgia syndrome] and resistance to conventional treatment. Thus, cannabinoids may be considered for FMS treatment.".
NORML
JANUARY 30, 2023
“These findings contribute robust evidence for clinicians regarding the potential benefits of medical cannabis in reducing the opioid burden for patients receiving long-term opioid therapy and possibly reduc[ing] their risk for overdose.”
NORML
APRIL 6, 2023
The millions of Americans who rely upon medical cannabis products ought to be afforded the same entitlements as those who use other conventional medications and therapies. The post NORML Op-Ed: States Should Require Insurers to Pay for Medical Cannabis appeared first on NORML.
Americans for Safe Access
AUGUST 12, 2024
Today, cannabis-based therapies provide relief to over 6 million Americans registered in medical cannabis programs in 38 states, D.C., A letter from ASA Founder & President The positive impacts of medical cannabis on patients and the healthcare systems that serve them are profound and far-reaching. and four of the five U.S.
NORML
FEBRUARY 1, 2019
They reported that 30 percent of participants discontinued their use of anti-anxiety medications within two-months of initiating cannabis therapy, and that 45 percent did so by six-months.
NORML
JUNE 19, 2020
Authors concluded, “Taken together, the results of this study add to the cumulative evidence in support of plant-based MC (medical cannabis) as a safe and effective treatment option and potential opioid substitute or augmentation therapy for the management of chronic pain symptomatology and quality of life.”
NORML
APRIL 11, 2023
"Passage of this legislation will provide qualified patients with a state-sanctioned option to access a therapy that has proven to offer significant benefits." The post Texas: House Lawmakers Advance Legislation Expanding Access to Medical Cannabis Products appeared first on NORML.
NORML
MAY 19, 2020
House Bill 819 , which House members passed by a vote of 77 to 15, expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that he or she “considers debilitating to an individual patient and is qualified through his [or her] medical education and training to treat.”
NORML
MAY 27, 2020
Members voted 28 to 6 in favor of an amended version of House Bill 819, which expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that he or she “considers debilitating to an individual patient and is qualified through his [or her] medical education and training to treat.”
NORML
FEBRUARY 25, 2020
.” The study’s findings are consistent with those of numerous other papers reporting that patients typically mitigate their use of opioids following the initiation of cannabis/cannabinoid therapy. Additional information on the relationship between cannabis and opioids is available in the NORML fact-sheet here.
NORML
JUNE 10, 2020
.” Furthermore, pain patients enrolled in medical cannabis access programs typically report decreasing or even eliminating their use of opiates after initiating cannabis therapy. ” Public comments “are part of the public record and are subject to public disclosure.
NORML
AUGUST 27, 2019
Over 146,000 Oklahomans are registered with the state to access medical cannabis therapy. .” It also allows podiatrists to make medical cannabis recommendations, among other changes.
Leafly
DECEMBER 20, 2021
More science supports cannabinoid therapies for autism symptoms. The post Dr. Sanjay Gupta adds to chorus of cannabis research on autism in 2021 appeared first on Leafly.
Project CBD
OCTOBER 26, 2023
See chapter: Using Cannabis Oil with Traditional Cancer Therapies). There is no consistently successful pharmaceutical drug therapy available to treat it, and while temozolomide is one of the best pharmaceuticals currently used, efficacy on its own is sorely lacking. GBM is a highly aggressive brain tumor with a very poor prognosis.
Americans for Safe Access
JULY 29, 2020
Just like prescription medication, diet and exercise, cannabis can impact other therapies and treatments you may be using, so it's important to make sure whoever you're working with has the full picture and can monitor your progress or make adjustments if needed.
NORML
DECEMBER 3, 2019
Adult-use retail cannabis access is associated with a decline in the sales of over-the-counter (OTC) sleep aid medications, according to data published in the journal Complimentary Therapies in Medicine.
MMJ Recs
MAY 23, 2024
We will be exploring cannabis therapy for chronic conditions. From alleviating symptoms to offering long-term relief, the exploration of cannabis therapy for chronic conditions is becoming increasingly pertinent in medical discourse. Typically, it can last for weeks, months, or even years.
CannaMD
AUGUST 4, 2022
As medical marijuana continues to gain acceptance across the United States and beyond, patients are increasingly turning to cannabis-based therapies as a complement or alternative to prescription pharmaceutical drugs.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content